CASK Form 4: Director Receives 13,315 Common Shares and 252,994 Pre-Funded Warrants
Rhea-AI Filing Summary
Matthew J. Swann, a director of Heritage Distilling Holding Company (ticker: CASK), reports transactions converting preferred shares into common stock and pre-funded warrants. The filing corrects a prior omission that on 06/27/2025 he acquired 10,000 shares of Series B Convertible Preferred Stock. On 08/15/2025 he exchanged those 10,000 Series B shares for 13,315 shares of common stock and pre-funded warrants to purchase an aggregate of 252,994 common shares pursuant to an exchange agreement. The reported common shares owned following the transaction are 119,065 (direct). The pre-funded warrants become exercisable on staged conditions: one set earliest of three months or if stock closes at or above $1.50; the other set earliest of six months or if stock closes at or above $2.00.
Positive
- Conversion to common stock increases the reporting person’s direct common equity stake to 119,065 shares, aligning interests with common shareholders
- Pre-funded warrants provide structured optionality with clear exercisability conditions, creating a path for future investment rather than immediate free dilution
- Correction filed reports an earlier omitted acquisition of 10,000 Series B shares, improving disclosure completeness
Negative
- Potential dilution from pre-funded warrants totaling 252,994 shares if exercised, which could materially increase share supply
- Prior omission of the June 27, 2025 Series B acquisition required a corrective filing, indicating a lapse in timely disclosure
Insights
TL;DR: Director swapped preferred for common and large pre-funded warrants, creating potential dilution and optionality tied to price hurdles.
The exchange converts illiquid preferred shares into immediately owned common shares plus pre-funded warrants exercisable on specified conditions, increasing the director's direct common share stake to 119,065 shares and creating contractual rights to an additional 252,994 shares if exercised. For investors this raises potential near- to medium-term supply of common stock depending on warrant exercisability and market price. The correction noting the June acquisition improves disclosure completeness but highlights an earlier reporting omission.
TL;DR: Transaction is routine insider conversion but the prior omission required correction, a minor governance flag.
From a governance perspective the filing documents a standard exchange agreement converting preferred into common and pre-funded warrants, aligning the director's economic exposure with common shareholders. The corrected disclosure of the June preferred acquisition resolves an earlier reporting gap; however, timely initial reporting is important for Section 16 transparency. The size of the warrants relative to outstanding shares may be material to shareholder dilution analysis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Series B Convertible Preferred Stock | 10,000 | $0.00 | $0.00 |
| Other | Pre-Funded Warrant to Purchase Common Stock | 133,155 | $0.00 | $0.00 |
| Other | Pre-Funded Warrant to Purchase Common Stock | 119,839 | $0.00 | $0.00 |
| Other | Common Stock | 13,315 | $0.00 | $0.00 |
| Purchase | Series B Convertible Preferred Stock | 10,000 | $10.00 | $100K |
Footnotes (4)
- F1. On August 15, 2025, the reporting person exchanged 10,000 shares of Series B Convertible Preferred Stock for (i) 13,315 shares of common stock, par value $0.0001 per share (the "Common Stock"), of Heritage Distilling Holding Company, Inc. and (ii) pre-funded warrants to purchase an aggregate of 252,994 shares of Common Stock pursuant to an exchange agreement.
- F2. The reporting person acquired shares of Series B Convertible Preferred Stock on June 27, 2025, which were inadvertently omitted from the reporting person's prior filings. This Form 4 corrects the prior omission by reporting such acquisition.
- F3. The pre-funded warrant reported herein will become exercisable on the earlier of (i) three months after the date of issuance of such warrant or (ii) the first trading day after the date of issuance of such warrant on which the closing price of the Common Stock equals or exceeds $1.50 per share.
- F4. The pre-funded warrant reported herein will become exercisable on the earlier of (i) six months after the date of issuance of such warrant or (ii) the first trading day after the date of issuance of such warrant on which the closing price of the Common Stock equals or exceeds $2.00 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
